Unfortunately some people find it hard to move on.
Now with the new cornerstone shareholders, with a better understanding of the medical industry, we can hopefully finally to get this company to start making meaningful sales followed by significant profits.
If I ever need a TAVR repair I'll be asking for one of these....providing their final testing is successful, which it is certainly starting to look the part.
I would like to think, if Admedus' TAVR ticks all the necessary boxes, that this will be getting significant news in the Medical columns shortly and if surgeons start using it as their first choice, then the other products in the ADAPT space will finally get a lot more recognition.
TAVR could be our game-changer.
IMO
Regards
Dabru
Ann: Promising Interim Results from TAVR Animal Study, page-25
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |